FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved Endo USA, Inc.'s supplemental application for a delayed-release tablet combining doxylamine succinate and pyridoxine hydrochloride (10 mg/10 mg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea and Vomiting in Pregnancy

Drugs mentioned

• Doxylamine succinate and pyridoxine hydrochloride, delayed-release tablets (Doxylamine succinate and pyridoxine hydrochloride)

Snippet

SUPPL AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE, DELAYED RELEASE TABLETS 10 MG/10 MG)